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Abstract
Background: As the development of neuropathic symptoms contributes to pain se-
verity and chronification after surgery, their early prediction is important to allow 
targeted treatment.
Objectives: We longitudinally investigated trajectories of signs and symptoms in 
patients undergoing thoracotomy and assessed whether and at which time they were 
related to the development of neuropathic pain symptoms 6 months after surgery.
Methods: Presurgical and 6 monthly postsurgical assessments included questionnaires 
for mental and physical well-being (e.g., depression/anxiety, pain catastrophizing, sleep 
quality, neuropathic pain symptoms), and quantitative sensory testing (QST).
Results: QST trajectories indicated nerve impairment of the surgery site with predomi-
nant loss of function. Signs of recovery towards the end of the assessment period were 
observed for some tests. Unsupervised cluster analysis with NPSI scores 6 months 
after surgery as clustering variable identified one group with no/low levels of neuro-
pathic symptoms and one with moderate levels. The two groups differed w.r.t. several 
signs and symptoms already at early time points. Notably, neuropathic pain anywhere 
in the body differed already preoperatively and sleep impairment differentiated the two 
groups at all time points. Regression analysis revealed three factors that seemed par-
ticularly suited to predicted 6 months NPSI scores, namely preoperative neuropathic 
pain symptoms, with contributions from sleep impairment 1 month after surgery and 
the presence of dynamic mechanical allodynia 3 months after surgery.
Conclusions: Clinical routine should focus on the individual's physiological state, 
including pre-existing neuropathic pain and sleep quality to identify patients early 
who might be at risk to develop chronic post-surgical neuropathic pain.
Significance: Development of neuropathies contributes to pain severity and pain 
chronification after surgery. Here we demonstrate trajectories of quantitative sensory 
tests (assessed at monthly intervals for 6 months after surgery) that reveal accurate time 
courses of gain/loss of nerve function following thoracotomy. Independent of the degree 
of neuropathic signs after surgery, the main predictors for post-surgical neuropathic pain 
are self-reported neuropathic pain before surgery and sleep quality shortly after surgery.
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1 |  INTRODUCTION
Chronic post-surgical pain (CPSP) is increasingly recog-
nized as major complication of many surgical procedures. 
Across surgery types, the prevalence of moderate CPSP is 
around 13% 12 months after surgery (Fletcher et al., 2015). 
Risk factors identified for CPSP include type of surgery 
(Fletcher et al., 2015), existence of preoperative pain (Abbott, 
Tyni-Lenne, & Hedlund, 2011; Fletcher et al., 2015), sever-
ity of acute postoperative pain (Bayman, Parekh, Keech, 
Selte, & Brennan, 2017; Fletcher et al., 2015), age (Pereira 
et  al.,  2017), psychological distress (in particular pain cat-
astrophizing (Jackson, Tian, Wang, Iezzi, & Xie,  2016; 
Weinrib et al., 2017), anxiety (Jackson et al., 2016; Weinrib 
et  al., 2017) and depression (Jackson et  al., 2016; Weinrib 
et al., 2017)). As a neuropathic component appears to con-
tribute to pain severity and chronification (Duale et al., 2014; 
Fletcher et al., 2015; P. M. Lavand'homme, Grosu, France, & 
Thienpont, 2014), it has been suggested that diagnosis of neu-
ropathic symptoms, as early as possible, is important (Hayes, 
Browne, Lantry, & Burstal, 2002; P. Lavand'homme, 2017) 
to allow targeted treatment.
The prevalence of CPSP with a neuropathic compo-
nent differs across surgical procedures (Duale et al., 2014; 
Haroutiunian, Nikolajsen, Finnerup, & Jensen,  2013), 
probably because of different likelihoods of surgery-re-
lated nerve injury. Besides breast surgery, thoracic sur-
gery is associated with the highest rates of neuropathic 
CPSP (Duale et  al.,  2014; Haroutiunian et  al.,  2013). 
The 6-month prevalence of CPSP following thoracot-
omy is around 35%–60% (Bayman & Brennan,  2014; 
Montes et  al.,  2015) with 30%–40% of these patients 
displaying probable or definitive signs of neuropathy 
(Duale et  al.,  2014; Guastella et  al.,  2011; Haroutiunian 
et al., 2013). In addition to a history of a relevant neuro-
logical lesion and/or a neuroanatomically plausible pain 
distribution, the diagnosis of neuropathic pain requires the 
presence of sensory signs (Finnerup et al., 2016). Sensory 
signs can be negative (i.e., loss of function) or positive 
(i.e., gain of function) (Treede et al., 2008) and can be as-
sessed using questionnaires such as the Neuropathic Pain 
Symptom Inventory (NPSI) (Bouhassira et  al.,  2004) or 
examinations such as quantitative sensory testing (QST) 
(Rolke et al., 2006). While both methods have been used 
to confirm probable neuropathic pain following thoracot-
omy (Duale et al., 2014; Guastella et al., 2011), no study 
has performed QST at multiple monthly time points after 
surgery to characterize trajectories of neuropathic signs. 
Consequently, important questions that remain unan-
swered concern the time courses of gain and loss of func-
tion following thoracotomy and whether the presence of 
these signs before or shortly after surgery can predict the 
degree of neuropathic CPSP.
Therefore, the main intention of this article was to de-
scribe QST trajectories after thoracotomy with a high density 
of testing time points to describe onset and recovery of neu-
ropathic signs after thoracotomy. A second aim was to pre-
dict the chronification of neuropathic symptoms using QST 
performed at early post-surgical time points (up to 3 months 
after surgery). Lastly, questionnaires were used as additional 
measures to explain further variance.
2 |  METHODS
To answer the research questions outlined above, we investi-
gated patients undergoing posterolateral thoracotomy before 
(baseline) and at monthly intervals up to 6 months following 
surgery. Baseline assessment included questionnaires to as-
sess pre-existing neuropathic pain anywhere in the body, anx-
iety, depression, pain catastrophizing and sleep impairment, 
and a brief QST protocol. Monthly post-surgical assessments 
included the same questionnaires and a more extensive QST 
assessment (applying the protocol of the German Research 
Network on Neuropathic Pain (Rolke et al., 2006), plus ther-
mal wind-up). As outcome measure, we used NPSI scores 
6 months after surgery.
2.1 | Study design
This study followed a prospective design investigating 
the development of neuropathic symptoms, using QST 
and questionnaires in patients before and up to 6 months 
after posterolateral thoracotomy. The study was ap-
proved by the local ethics boards of McGill University 
and the Montreal General Hospital. Patients gave written 
consent to partake in the study and all study procedures 
were in accordance with the declaration of World Medical 
Association (2013).
2.2 | Participants
We recruited 74 participants scheduled to undergo postero-
lateral thoracotomy, of which 37 were included in the final 
analysis. As depicted in the flow chart (Figure  1), the re-
duction in number was primarily due to the development of 
complications following surgery, and missing baseline data. 
Patients were initially approached by clinical staff at the 
Montreal General Hospital during their preoperative clinical 
assessment and, if they expressed an interest in the study and 
agreed to be contacted, received more information by a mem-
ber of our research team. Of the final study sample of N = 37, 
20 were men and 17 women. The majority of patients were 
diagnosed with lung cancer and underwent partial or full 
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resection of one lung through a posterolateral thoracotomy 
(Table 1).
2.3 | Anaesthesia and post-operative 
analgesic regime
Two large-bore intravenous cannulas and an arterial line 
were placed before induction of anaesthesia.
An epidural catheter was inserted at the T4-T5 or T5-6 
level and balanced General Anaesthesia was induced with 
a double-lumen endotracheal tube to isolate and deflate the 
non-dependent (operative) lung, maintaining one-lung ven-
tilation throughout the surgery. Intraoperative anaesthesia/
analgesia management was left to the attending anaesthe-
siologist, but always included opioids (fentanyl, sufentanyl 
and/or remifentanil), muscle relaxants and a gas (such as 
sevofluorane or desfluorane) or total intravenous anaesthe-
sia. Once the surgery was completed and the chest tubes 
were in working mode, patients received ondansentron 
and ketorolac, were awakened and transferred to the Post 
Anesthesia Care Unit (PACU). The analgesia and respira-
tory function were optimized in the PACU before trans-
fer to the ward with the epidural catheter and multimodal 
analgesia. Epidurals were kept for 4  days, until the chest 
tube was removed. The standard protocol of the Acute Pain 
Service at the Montreal General Hospital for epidural solu-
tions is Bupivacaine 0.1% with Fentanyl 3ug/ml at rates 
between 7 and 10  ml per hour, with the possibility of a 
rescue bolus of 6–8 ml every 4 hr.
In addition to a functional continuous epidural block, 
postoperative standard multimodal analgesia involved cele-
coxib, acetaminophen and rescue oral opioids.
As per the standard Clinical Pathway for thoracotomies 
in our institution, patients get 975mg Acetaminophen orally, 
every 6 hr for 5 days then, every 6 hr only as needed, 100 mg 
Celecoxib orally, twice daily for 5 days, 5–7.5 mg Oxycodone 
orally, every 4 hr as needed, 15 mg Oxazepam orally, every 
night at bedtime as needed, 25–50 mg dimenhydrate intrave-
nously/orally, every 8 hr as needed, 100 mg Docusate orally, 
twice daily, on top of the epidural analgesia daily optimized 
by the Acute Pain Service.
F I G U R E  1  Flow chart of patient recruitment, drop outs and study population included in the final analysis
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2.4 | Surgery
Patients were positioned in the classic lateral decubitus posi-
tion for posterolateral thoracotomy. A posterolateral access 
to the thoracic cavity was created by dividing the skin and 
the muscular planes (latissimus dorsi and intercostal muscles, 
saving the serratus and rhomboid muscles), typically at the 
intercostal space T4-5. No costal resections were performed, 
and the intercostal muscles division was created on the su-
perior edge of the inferior rib in an attempt to preserve the 
intercostal nerve. A rib retractor was carefully positioned to 
separate the ribs and prevent rib fractures in the process.
2.5 | Measures
2.5.1 | Questionnaires
Neuropathic pain symptom inventory (NPSI)
Participants were asked to complete the NPSI at the beginning 
of every testing session. The NPSI is a validated self-report 
questionnaire evaluating different neuropathic symptoms, 
encompassing five sub-scales (burning spontaneous pain, 
pressing spontaneous pain, paroxysmal pain, evoked pain and 
dysesthesia/ paresthesia (Bouhassira et al., 2004)). The sub-
scale ‘burning spontaneous pain’ includes one item; ‘pressing 
spontaneous pain’, ‘paroxysmal pain’ and ‘dysesthesia/ par-
esthesia’ include two items each; and ‘evoked pain’ includes 
three items. Each item is rated on an 11-point Likert scale 
(ranging from 0 to 10). Scores for each sub-scale are divided 
by its number of items, resulting in a maximum score of 10 
(range 0–10) per sub-scale, and a maximum of 50 (range 
0–50) for the total NPSI score. Before surgery, participants 
were instructed to relate the phenomena described in the 
NPSI to symptoms anywhere in their body. After surgery, 
they were specifically instructed to relate the NPSI to symp-
toms perceived at or around the operation site on their thorax. 
The NPSI score of the participant's final visit (6 months after 
surgery for n = 35, and 5 months after surgery for n = 2 due 
to missing data for their 6th session) was used as the main 
outcome measure, i.e., neuropathic CPSP. For simplicity, we 
refer to this measure as ‘6 months NPSI score’ hereafter. The 
NPSI scores of the remaining time points served as predictor 
variable.
Hospital Anxiety and Depression Scale (HADS)
Participants were asked to complete the HADS (Zigmond & 
Snaith, 1983) at the beginning of every testing session. The 
HADS is a validated self-report questionnaire evaluating psy-
chological distress, encompassing two sub-scales, i.e., anxiety 
and depression. Each subscale consists of seven items, with 
each item being scored on a 0–3 scale, resulting in a maximum 
score of 21 per subscale and 42 for the total score.
Pain Catastrophizing Scale (PCS)
Participants were asked to complete the PCS (Sullivan, 
Bishop, & Pivik,  1995) at the beginning of every testing 
session. The PCS is a validated self-report questionnaire 
evaluating catastrophic thinking related to pain. It consists 
of 13 items in total and encompasses three sub-scales, i.e., 
T A B L E  1  Age, surgery-related data and baseline psychometrics 
for male and female patients
  Men Women
Number 20 17
Age (years, mean ± SD) 61 ± 16 58 ± 14
Surgery side
Left 10 7
Right 10 10
Diagnosis
Carcinoma 14 13
Sarcoma 0 2
Granuloma 0 1
Anthracosis 0 1
Lymphoma 1 0
Sarcoidosis 1 0
Schwannoma 1 0
COPD 1 0
Hamartoma 1 0
Cyst 1 0
Adjunct treatment
Chemotherapy 7 8
Radiotherapy 0 1
Psychometric baseline data
Depressive symptoms (HADS)
None (score of 0–7) 18 13
Mild (score of 8–10) 0 3
Moderate (score of 11–14) 2 1
Severe (score of 15–21) 0 0
Anxiety symptoms (HADS)
None (score of 0–7) 18 4
Mild (score of 8–10) 1 5
Moderate (score of 11–14) 1 8
Severe (score of 15–21) 0 0
Pain Catastrophizing (PCS, 
mean ± SD)
13 ± 2 10 ± 3
Sleep Impairment (PSQI, 
mean ± SD)
5 ± 1 7 ± 1
Abbreviations: COPD, chronic obstructive pulmonary disease; HADS, Hospital 
Anxiety and Depression Scale (maximum score per scale = 21); PCS, Pain 
Catastrophizing Scale (maximum score = 52); PSQI, Pittsburgh Sleep Quality 
Index (maximum score = 21); SD, standard deviation.
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rumination (4 items), magnification (3 items) and helpless-
ness (6 items). Each item is scored on a 0–4 scale, resulting 
in a maximum score of 52.
Pittsburg Sleep Quality Index (PSQI)
Participants were asked to complete the PSQI (Buysse 
et  al.,  1991) at the beginning of every testing session. The 
PSQI is a validated self-report questionnaire evaluating sleep 
quality of the previous month, with higher scores indicating 
greater sleep impairment. It encompasses seven subscales 
(i.e., subjective sleep quality, sleep latency, sleep duration 
habitual sleep efficiency, sleep disturbance, use of sleep 
medication and daytime dysfunction), which can each range 
from 0 to 3, resulting in a maximum total score of 21.
2.5.2 | QST protocol
For QST assessments, participants lay on their back. Tests 
were performed on the control site first, followed by the sur-
gery site (or eventual surgery site for the preoperative baseline 
assessment). To ascertain that the QST measures were indeed 
assessed within the area affected by the surgery the skin area 
around the scar was mapped for sensory alterations prior to 
testing. The skin was stroked using a SENSELab Brush-05 
(Somedic, Sweden), approaching the scar from seven direc-
tions (sparing the direction along the scar). Each stroke was 
2 cm long and was applied with a force of 20–40 mN and a 
speed of 2  cm/s. Strokes were first applied well outside the 
affected area and each subsequent brush stroke was applied 
slightly closer to the scar than the preceding one. The strokes 
were stopped as soon as the patient reported a change in sensa-
tion. The position of the last stroke was marked on the skin for 
each of the seven directions. The testing site of 2 by 4 cm was 
then determined within the mapped area, avoiding scar tissue 
and as distal to the scar tissue as possible. If participants did not 
report any changes in sensation during this mapping procedure, 
we chose a testing site 2 cm distal to the scar and following the 
fifth and sixth rib. The homologous contralateral site served as 
control site. During testing, the room temperature was kept at 
23°C and the participant`s skin temperature (measured using 
an infrared thermometer) for each testing site was documented.
QST assessments followed the protocol of the German 
Research Network on Neuropathic Pain (DFNS, (Rolke 
et al., 2006)): assessment of cold and warm detection thresh-
olds, and cold pain and heat pain thresholds was followed 
by assessments of mechanical detection and mechanical 
pain thresholds, mechanical pain sensitivity, presence of 
dynamic mechanical allodynia, vibration detection, PPT 
and mechanical temporal summation by calculating the me-
chanical wind-up ratio (WUR) (Rolke et  al.,  2006). In ad-
dition to the DFNS protocol, we tested thermal temporal 
summation (Staud, 2004; Staud, Vierck, Cannon, Mauderli, 
& Price, 2001). Details of the employed QST apparatus and 
methods are listed in Table 2.
One tester (L.N.) performed the QST in the participants (in 
31 out of 37). Two further testers (W.G. and C.W.) tested the 
remaining six participants (2 and 4, respectively). Each partic-
ipant was tested by only one tester, meaning that each tester al-
ways saw their participants through all seven testing sessions.
2.5.3 | Quality control—baseline QST
To ascertain that differences in the QST measures between 
control and surgery site indeed reflected the underlying tho-
racic nerve damage rather than general changes in sensitivity 
after surgery, we performed a shortened QST protocol before 
surgery (hereafter referred to as ‘baseline QST’) in 32 partici-
pants (the remaining participants, N = 5, were not available to 
undergo QST before surgery due to time constraints on their 
end). This additional baseline assessment allowed us to test (a) 
whether QST measures on the control site were stable across 
time by comparing baseline and post-surgical measures for 
the control site, and (b) whether the control and surgery site 
were comparable in their sensitivity before surgery by com-
paring control and surgery site measures for the baseline QST.
The baseline QST took place at the Montreal General 
Hospital at the day of the participant's pre-surgical clinical as-
sessment. Baseline QST was performed on the skin of patients’ 
anterolateral thorax on the midclavicular line between the fifth 
and sixth rib. The protocol comprised the assessment of me-
chanical detection threshold (MDT) and pressure pain thresh-
old (PPT) (details on methods and employed apparatus are 
presented in Table 2). These quantitative tests were followed 
by two qualitative tests assessing sensation in response to brush 
strokes using a SENSELab Brush-05 (Somedic, Sweden) and 
to a pinprick stimulus (Neuropen®; Owen Mumford Ltd.). 
Each stimulus was applied to the control site first and immedi-
ately afterwards to the surgery site. Participants were asked to 
indicate whether the stimuli felt the same on the two sites, or 
stronger or weaker on the surgery compared to the control site.
2.6 | Study procedures
2.6.1 | Baseline session
During the baseline session, a brief clinical interview was 
performed to obtain demographic data and a brief medical 
history including medications. Questionnaires were adminis-
tered to assess variables commonly reported to predict CPSP. 
Specifically, neuropathic pain symptoms anywhere in the 
body (NPSI; Bouhassira et al., 2004), depression and anxi-
ety (HADS; Zigmond & Snaith, 1983), pain catastrophizing 
(PCS; Sullivan et  al.,  1995) and sleep impairments (PSQI; 
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T A B L E  2  QST subtests, employed apparatus and their application
Subtest Method Apparatus
CDT Baseline temperature: 32°C
Rate of decreasing temperature: 0.5°C/s (CDT); 1°C/s (CPT)
Participant indicated: first cool sensation (CDT): first painfully cold sensation (CPT)
CDT: average temperature across three repetitions that participant indicated as cool
CPT: average temperature across three repetitions that participant indicated as just 
painfully cold
TSA-II-NeuroSensory 
Analyzer, Medoc Ltd. (Haifa, 
Israel); 16 x16 mm Peltier 
thermode
CPT
WDT Baseline temperature: 32°C
Rate of increasing temperature: 0.5°C/s (WDT); 1°C/s (HPT)
Participant indicated: warm sensation/painfully hot
WDT: average temperature across three repetitions that participant indicated as warm
HPT: average temperature across three repetitions that participant indicated as just 
painfully hot
HPT
Thermal WUR Applied temperature: 50°C
Application rate: 0.5 Hz
Stimulus: manually tapping the thermode onto the participant's skin for 700 ms (ISI 
1,300 ms)
Number of stimuli: 1 baseline stimulus and a series of 15 consecutive stimuli
WURth: maximum pain rating for the series of 15 stimuli was divided by the pain rating 
for the single baseline stimulus
MDT Method: modified method of limits using alternatingly five series of ascending stimulus 
intensity and five series of descending stimulus intensity, crossing the mechanical 
detection threshold 10 times
MDT: geometric mean across the five sub-threshold and five supra-threshold intensities
von Frey filaments, Opihair2-
Set, MARSTOCKnervtest 
(Schriesheim, Germany)
MPT Method: modified method of limits using alternatingly five series of ascending stimulus 
intensity and five series of descending stimulus intensity, crossing the mechanical pain 
threshold 10 times
MPT: geometric mean across the five sub-threshold and five supra-threshold intensities
Weighted Pinprick probes, 
MRC Systems GmbH 
(Heidelberg, Germany)
MPS To test pinprick hyperalgesia, weighted pinprick probes of various intensities (8mN, 
16mN, 32mN, 64mN, 128mN, 256mN, 512mN) were applied across five blocks, with 
each block containing one repetition of each intensity, presented in a pseudo-randomized 
order that differed for each block. Patients rated each stimulus in its intensity on a 0 (no 
pain) to 10 (most intense pain tolerable) numeric rating scale
MPS: geometric mean across all ratings
Mechanical 
WUR
Applied intensity: 256 mN
Application rate: 1 Hz
Number of stimuli: 1 baseline stimulus and a series of 10 stimuli; three repetitions
WURmech: maximum pain rating for the series of 10 stimuli was divided by the pain 
rating for the single baseline stimulus, calculating the arithmetic mean across the three 
repetitions
DMA The three tactile stimuli were each applied using a single stroke of approximately 2 cm 
across the skin, starting on the control site, followed by the surgery side. Patients were 
asked to compare the sensation on each side and indicate whether it felt less intense on 
the surgery compared to control side, the same on both sides, or more intense on the 
surgery side. Each stimulus pair (control and surgery side) was repeated three times
DMA: If participants reported the stimulation to be more intense on the surgery versus 
control side for a minimum of 1 test, while the remaining tests felt similarly intense on 
both sides, the presence of DMA was coded as 1. If patients perceived the intensity for 
all three tests as similar on both sides, or less intense on the surgery side, the absence of 
DMA was coded as 0
Set of three non-noxious tactile 
stimuli:
Cotton wisp (~3mN),
Cotton wool tip fixed on an 
elastic strip (~100 mN,
Standardized brush 
(~200−400mN, Somedic, 
Sweden)
VDT Vibrating tuning fork was placed on participant's rib (within the identified testing area), 
where it was held in place until participant indicated to no longer perceive vibration
VDT: arithmetic mean of the indicated disappearance threshold (as displayed by the 8/8 
scale) across three repetitions
Rydel Seiffer Neurological 
Tuning Fork (64 Hz, with 
8/8-scale)
(Continues)
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Buysse et al., 1991) were assessed. A subset of participants 
further underwent the baseline QST assessment as described 
in section 2.5.3.
2.6.2 | Post-surgical assessments
In the first 24 hr after surgery, clinical staff recorded acute 
post-operative pain intensity three times, using a 0–10 nu-
merical rating scale. After being discharged from the hospi-
tal, participants were contacted by a research team member 
to schedule an appointment for the first follow-up session 
1 month after the date of surgery.
2.6.3 | Post-surgical experimental sessions
Post-surgical experimental sessions were performed monthly, 
up to 6 months after surgery. In each of the follow-up ses-
sions participants were asked to complete pain drawings, in-
dicating on a 2-dimensional manikin (pen-and-paper) where 
on their body they perceived pain and—if any pain was re-
ported—how intense the pain was, using the above-described 
0–10 numerical rating scale. Patients further underwent the 
QST assessment and completed the questionnaires at the end 
of the session.
2.7 | Data analysis
2.7.1 | Quality controls
Comparison of control and surgery sites before surgery
Baseline MDT and PPT values for control and surgery site 
were normally distributed in log space and therefore loga-
rithmically transformed before comparing the two sites 
using paired t-tests. Brush stroke and pinprick sensations 
were coded in binary fashion with 0 indicating no difference 
between sites and 1 indicating a difference in perceived in-
tensity between the sites. Sites were compared using a chi-
square test.
Stability of QST measures on the control site over time
To differentiate whether any post-surgical changes on the 
surgery site are restricted to the surgical site or represent 
generalized phenomena after surgery, we tested whether 
sensitivity on the control site remained stable over time. 
We performed this assessment for the two quantitative 
subtests obtained during the baseline session, i.e., PPT 
(n = 30) and MDT (n = 32). As data were not normally dis-
tributed, Wilcoxon signed rank test for dependent samples 
was used to compare QST thresholds on the control side 
for each post-surgical time point to its respective baseline 
value.
2.7.2 | Post-surgical QST trajectories
Thresholds for all QST subtests were compared between sur-
gery and control site for each of the post-surgical time points. 
Because data were not normally distributed (even after log-
transformation), Wilcoxon signed rank test for dependent 
samples was used.
To further assess whether QST signs after surgery indicated 
recovery/worsening over time or remained stable across the 
study period, ordinary least squares regression was performed, 
using time (months after surgery) as the independent variable 
and the QST measures on the surgery site for each subtest as the 
dependent variable. Standardized betas are reported to describe 
the linear trend of each QST sign over time.
2.7.3 | Normalization of post-surgical 
QST data
For the remaining analysis patients’ QST scores for the 
surgery site were normalized using the six time points of 
each individual's control site as reference—i.e., z = (val-
uesurgery site − meancontrol site across all six time points)/SDcontrol site 
across all six time points. The aim of this approach was to control 
for any general alteration of an individual in sensitivity 
following surgery, thereby obtaining QST scores more 
directly associated with the underlying nerve damage. 
Subtest Method Apparatus
PPT Pressure algometer was placed in between ribs (within the identified testing area) and 
pressure slowly increased until participant indicated the pressure to be just painful
Increasing rate: ~0.5 kg/cm2 s
PPT: arithmetic mean of the indicated pain threshold across three repetitions
Pressure algometer FDN200 
with rubber tip (probe area of 
1 cm2), Wagner Instruments 
(Greenwich, CT, USA)
Abbreviations: CDT, cold detection threshold; CPT, cold pain threshold; DMA, dynamic mechanical allodynia; HPT, heat pain threshold; MDT, mechanical detection 
threshold; MPS, mechanical pain sensitivity; MPT, mechanical pain threshold; PPT, pressure pain threshold; VDT, vibration detection threshold; WDT, warm 
detection threshold; WUR, wind-up ratio.
T A B L E  2  (Continued)
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Before transforming the data, it was assured that central 
sensitization following surgery or differences between the 
control and test site at baseline were not present in our 
patient population, as these factors would have jeopard-
ized the approach taken (see methods for quality control 
checks above in section 2.7.1 and their results below in 
section 3.2.1).
Because some participants did not perceive the single stim-
ulus of either or both of the temporal summation assessments 
(WURmechanical and WURthermal) on the affected site following 
surgery but did perceive the series of repeated stimulation as 
painful, the resulting WUR mathematically approaches infinity. 
To give justice to the fact that these patients clearly showed tem-
poral summation, while keeping the variance across the group 
at a reasonable level, we conservatively put the WUR values 
of these patients to `9’ (i.e., as if the series was rated as a 9 and 
the single stimulus as a 1) before normalizing the WUR data. A 
score of 9 corresponded to 6.1SD and 6.2SD above the meansur-
gery site of the remaining participants’ data for WURmechanical and 
WURthermal, respectively (with a range of 0–7.5 for mechanical 
and 0–8 for thermal WURs).
2.7.4 | Linear Regression Analysis to 
identify early predictors of chronic post-
operative neuropathic pain
A step-wise linear regression analysis was performed to 
assess the predictive values of QST and questionnaire 
data for the 6-months’ NPSI score. For data reduction, we 
only entered variables that significantly correlated with 
6-months NPSI scores using Pearson's correlation coeffi-
cient (p < .05). Dummy variables were defined for the two 
categorial measures (gender, male = 1 and female = 2; and 
DMA, 0 = absence of DMA and 1 = presence of DMA on 
the surgery site).
Because the aim was to predict neuropathic pain at the 
earliest time point possible, we used a step-wise regres-
sion, entering identified baseline variables only into the 
first model, followed by variables at 1  month after sur-
gery (2nd model), 2 months after surgery as the final step 
(3rd model), and finally added variables at 3 months after 
surgery as the final step (4th model). Thus, the regression 
analysis provided us with the opportunity to examine the 
best combination of pre- and early post-operative factors 
to predict 6 months NPSI scores after surgery at the ear-
liest time point(s) possible. Adjusted coefficients of de-
termination (adjusted R2) were calculated for each model 
to assess the variance of the dependent variable that was 
explained by each model. Standardized betas are reported 
for all variables that significantly predicted the dependent 
variable within the best suited model (based on signifi-
cant changes in explained variance). Given the relatively 
large number of factors within the regression model and a 
sample size of 37 participants, there was a risk for the re-
gression model of being underpowered, thereby limiting 
external validity of the findings. Therefore, we performed 
an additional linear regression enter model with the same 
dependent variable (6-months NPSI scores) but including 
only independent variables that were identified as predic-
tors for 6-months NPSI scores by the previous step-wise 
regression model. A confirmation of the previous results 
by this additional analysis would be interpreted as sup-
porting the external validity of the findings.
2.7.5 | Subgroups of patients with different 
levels of chronic neuropathic pain symptoms
Taking an exploratory approach, we performed a two-
step unsupervised cluster analysis to distinguish between 
patients with different levels of neuropathic symptoms 
6 months after surgery, with the intend to identify varia-
bles (using QST and questionnaire data) that distinguished 
between these groups. In a first step of the unsupervised 
cluster analysis, two clusters were identified within the 
present sample with good cluster quality (silhouette meas-
ure of cohesion and separation >0.5). In a second step, a 
k-mean cluster analysis with k = 2 clusters was performed. 
Convergence criterion was set at 0, with a maximum num-
ber of iterations of 50. Cluster membership and Euclidian 
distance to the cluster centre were inspected, and dis-
tances to the cluster centre were compared between the 
two subgroups (as defined by cluster membership) using 
a Mann–Whitney U test for independent samples. The 
two identified groups were further compared in the spe-
cific self-reported neuropathic pain symptoms across time 
(based on the NPSI sub-scales) using a Mann–Whitney 
U test, their demographic data—i.e., age using a Mann–
Whitney U test for independent samples, and gender dis-
tribution using a chi-square test—pre-existing neuropathic 
pain symptoms, acute post-OP pain and all questionnaire 
data (i.e., HADS, PCS, and PSQI) using Mann–Whitney 
U tests for independent samples. To compare post-surgi-
cal QST data between patients with no/low and moderate 
6-months NPSI scores DMA was coded in binary fashion 
with 0 indicating the absence of DMA and 1 indicating 
the presence of DMA on the surgery site. Groups with no/
low versus moderate 6-months NPSI scores were com-
pared using a chi-square test. For the QST subtests with 
quantitative data, normalized post-surgical QST data were 
compared for all time points between the group with no/
low versus moderate 6-months’ NPSI scores using Mann–
Whitney U tests for independent samples. Non-parametric 
test statistics were chosen because of the relatively small 
group sizes (i.e., 7 versus. 30).
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All analysis was performed using IBM SPSS Statistics, 
version 24 (IBM Corp.). Data are presented in mean ± SD for 
parametrically analysed data and as median and 95% confi-
dence interval (CI) for non-parametrically analysed data. The 
significance level was set to p < .05.
3 |  RESULTS
3.1 | Neuropathic pain symptoms 6 months 
after surgery
The median of the 6-months NPSI score was 2.00(95% CI 
[1.67; 4.87], range 0–23). Of the 37 patients, 24 reported a 
score higher than zero and, thus, indicating the presence of 
some neuropathic symptoms.
3.2 | QST analysis
3.2.1 | Quality Controls
Testing site corresponds to self-reported pain after 
surgery
All patients reported pain at their first post-surgical visit. 
Inspecting the respective pain drawings revealed that 36/37 
patients indicated their pain to be located on the surgery side 
of the anterolateral thorax, including the area that we used as 
testing site for the QST measures. A majority of these patients 
(33/37) reported additional pain sites (mostly on their backs, 
along the scar tissue that had resulted from the thoracic sur-
gery). Only 1/37 patients reported their pain to be at a site 
different to the one used as testing site for the QST (i.e., on his 
back along the scar tissue but not on the anterolateral thorax). 
Based on these findings, we conclude that functional abnor-
malities identified via QST measures were located within the 
same area as the pain that was perceived following surgery, 
i.e., the innervation area of the affected intercostal nerve.
Comparison of control and surgery sites before surgery
Baseline data of MDT (n = 32), PPT (n = 30), and differ-
ences in brush stroke (n = 28) and pinprick sensation (n = 29) 
were compared between control and surgery sites. Analysis 
revealed no differences for any of the performed tests (Table 
3), indicating that the sensitivity of the control and surgery 
sites was comparable before surgery.
Stability of QST measures on the control site over time
For the two quantitative tests of the baseline assessment 
(i.e., MDT and PPT), we further tested whether the sensitiv-
ity of the control site changed over time following surgery 
(Figure 2). For both tests, none of the post-surgical thresholds 
differed significantly from the pre-surgical baseline measure-
ments (Table 4).
The performed quality checks thus indicated that differ-
ences in the QST measures between control and surgery site 
(described hereafter) do reflect changes in sensitivity within 
the innervation area of the affected intercostal nerve rather 
than general changes in sensitivity after surgery.
3.2.2 | QST trajectories for the surgery site
Comparison of post-surgical and baseline data for MDT 
and PPT for the surgery site
In contrast with the control site, all time points for MDT and 
most time points for PPT (time point 1 through 5) after sur-
gery differed significantly compared to baseline on the sur-
gery site (Table 4). Results showed an increase in mechanical 
detection thresholds following surgery (indicating a loss of 
function) and decreased thresholds for pressure pain (indicat-
ing a gain of function).
T A B L E  3  Control and surgery sites before surgery
  Control site (mean ± SD)
Future surgery site 
(mean ± SD) N t p
MDT (mN) 5.41 ± 9.05 7.40 ± 12.01 32 0.78 .441
PPT (kg/cm2) 2.60 ± 0.90 2.63 ± 0.86 30 0.32 .749
 
Number of participants who found 
stimulations between control and future 
surgery site
N Χ2 pComparable Different
Brush stroke 26 3 28 0.07 .782
Pin prick 24 5 29 0.17 .684
Note: MDT and PPT, data were log-transformed for the analysis.
Abbreviations: MDT, mechanical detection threshold; PPT, pressure pain threshold.
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Comparison of post-surgical QST data between control 
and surgery site
Comparing surgery and control sites for all post-surgical 
time points (Table 4), it was found that the surgery site 
exhibited predominant signs of a loss of nerve function 
(Figures 2a and 3). CDT, WDT, HPT, MDT, MPT, MPS 
and VDT showed significant differences between surgery 
and control site for all time points following surgery (all 
z's ≤ −2.79, all p's ≤  .005). CPT results showed reduced 
sensitivity to cold pain on the surgery site for the first 
three months after surgery and 5 months after surgery (all 
z's ≤ −2.09, all p's ≤ .037), but no difference at 4 months 
(z=−0.85, p = .394) and 6 months (z=−1.31, p = .192)—
with a positive linear trend of CPT signs on the surgery site 
over time (standardized beta = 0.13, p = .049), indicating 
recovery of nerve function towards the end of the study 
period. Further linear trends indicating recovery from loss 
of function following surgery were found for CDT (stand-
ardized beta  =  0.15, p  =  .023) and MDT (standardized 
beta = −0.13, p = .046, Figure 2a). For all remaining tests 
that had shown loss of nerve function (WDT, HPT, MPT, 
MPS and VDT) sings remained stable after surgery with 
linear trends over time that were not differed from zero (all 
standardized beta's < |0.10|, all p's ≥ .160).
PPT was the only test showing a gain of function on the 
surgery site (Figure  2b), with all time points after surgery 
showing significant differences between surgery and con-
trol site (all z's ≤ 2.81, all p's ≤ .005, Table 4). The slope of 
PPT over time revealed no linear trend of recovery within 
the 6  months following surgery (standardized beta  =  0.11, 
p = .115).
Neither of the temporal summation measures 
(WURmechanical and WURthermal) was affected by surgery: none 
of the post-surgical time points differed significantly between 
surgery and control site for either test (all Z’s ≤ −1.74, all 
p's ≥ .081).
3.3 | Early predictors of neuropathic pain 
symptoms 6 months after surgery
For clinical practice, tests are needed to identify patients at 
risk to develop chronic neuropathic pain following surgery 
as early as possible, ideally before symptoms are chronic. 
We thus entered all variables assessed at an early time 
point (from baseline to 3 months following surgery)—QST 
and questionnaire data—that correlated significantly with 
6-months NPSI scores into a step-wise regression (Table S1 
depicts all correlation coefficients). Within this regression 
model, we entered identified baseline variables first (i.e., 
baseline NPSI and PSQI scores), followed successively by 
variables assessed 1 month (i.e., PSQI scores, PCS scores, 
HADS depression score), 2 months (i.e., PSQI scores, PCS 
scores, HADS depression and anxiety scores), and 3 months 
(i.e., PSQI scores, PCS scores, HADS depression and anxi-
ety scores, HPT z-score, MPS z-score, presence of DMA) 
after surgery, to identify the earliest time point to predict the 
outcome measure. All test assumptions for linear regression 
were met (i.e., no outliers, all variables were multivariate 
normal, no auto-correlations, i.e., independence of observa-
tions, as assessed by a Durbin-Watson statistic of 2.27, and 
the presence of homoscedasticity).
The four models tested within the step-wise procedure 
explained significant variance of neuropathic pain symp-
toms 6 months after surgery. While model 2 and 3 (each 
p >  .10) did not explain significantly more variance than 
model 1 (adjusted R2  =  0.61, change in F3,33  =  19.71, 
p  <  .001), model 4 explained more variance compared 
F I G U R E  2  (a) MDT and (b) PPT illustrate that sensitivity of the control site (in black, dashed line) was stable across the seven time points of 
the experiment (no differences were found between any of the post-surgical time points and baseline). In contrast, the surgery site (in red, solid line) 
showed impairments in sensitivity after surgery across the whole patient sample, with all (MDT) or the first five time points (PPT) after surgery 
being significantly different from baseline. Comparing control and surgery site to each other revealed no differences at baseline but significant 
differences for all post-surgical time points (MDT and PPT). Depicted are means and SD. BL, baseline
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to the previous models (change in F7,19 = 3.69, p = .011, 
Table S2a). Of the variables included in model 4 (adjusted 
R2  =  0.80, p  <  .001), neuropathic pain symptoms before 
surgery (standardized ß = 0.54, p < .001), sleep impairment 
1 month after surgery (standardized ß = 0.29, p =  .052), 
and presence of dynamic mechanical allodynia at 3 months 
(standardized ß  =  0.33, p  =  .007) predicted NPSI scores 
6  months after surgery (Figure  4). This result indicates 
that neuropathic pain symptoms anywhere in the body 
before surgery, in combination with sleep impairments 
and the presence of dynamic allodynia shortly after sur-
gery should be taken into consideration as early measures 
when predicting the level of neuropathic pain symptoms 
6 months after surgery. It should, however, be noted that 
the p-value for sleep impairment 1 month after surgery was 
just above the pre-defined significance level of p = .05 and 
that dynamic mechanical allodynia as a predictor should 
also be taken with caution because of the very low number 
of patients with DMA (three at 3 months after surgery).
To support external validity of our data, we performed a 
multivariate linear regression. This analysis confirmed that 
all three factors (neuropathic pain symptoms before sur-
gery, sleep quality 1  month after surgery and the presence 
of dynamic mechanical allodynia 3  months after surgery) 
F I G U R E  3  For most QST subtests, i.e., (a) CDT, (b) CPT, (c) MPS, (d) VDT, (e) WDT, (f) HPT, and (g) MPT, comparing control site (in 
black, dashed line) and surgery site (in red, solid line) revealed loss of function on the surgery site, i.e., surgery-induced loss of function. Depicted 
are means and SD. *p < .05, **p < .01, ***p < .001
F I G U R E  4  Neuropathic pain symptoms (with a maximum score of 50) anywhere in the body before surgery (a), sleep impairment (with 
a maximum score of 21) 1 month after surgery (b), and presence of dynamic mechanical allodynia (c) predicted the level of neuropathic pain 
symptoms that patients reported six months after surgery. Stand, beta standardized beta; NPSI, neuropathic pain symptom inventory; PSQI, 
Pittsburgh Sleep Quality Index; DMA, dynamic mechanical allodynia
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significantly predicted neuropathic pain symptoms 6 months 
after surgery (adjusted R2 = 0.74, p < .001, Table S2b).
3.4 | Comparing patients with low versus 
moderate 6 months NPSI scores
Un-supervised cluster analysis of the 6 months NPSI scores 
identified two sub-groups of uneven numbers, but with 
similar mean distances to the respective cluster centres 
(p = .128): n = 30 participants with no or low neuropathic 
pain symptoms 6 months after surgery (median pain = 1.00, 
95% CI = 0.78–2.02), and a small group of n = 7 with moder-
ate neuropathic pain symptoms (median pain = 10.00, 95% 
CI  =  6.06–16.51, U  =  0, p  <  .001, Figure  5). The cut-off 
score that distinguished between the two groups was 5. The 
distribution of group classification (low versus. moderate 
6  months NPSI scores) was equal across the three differ-
ent testers (as tested by Kruskal–Wallis test for independent 
samples, p = .759).
Comparing the two groups for their specific neuropathic 
symptoms based on the NPSI sub-scales revealed that pa-
tients with moderate 6-months NPSI total scores reported 
significantly higher levels of burning spontaneous pain 
sensations and paroxysmal pain than patients with no/low 
6-months NPSI scores for all post-surgical testing time 
points, and significantly higher levels of pressing sponta-
neous pain sensations and dysesthesia/paresthesia for most 
post-surgical testing time points. Evoked pain, in contrast, 
was reported to be similarly low for both groups (for more 
details see Table S3 and Figure S1 of the supplementary 
material).
Both groups were similar in age and did not differ in their 
gender distribution (Table 5). Furthermore, the two groups 
did not differ w.r.t. pain and sleep quality ratings immediately 
after surgery (assessed within 24 hr after surgery) (Table 5). 
In contrast, neuropathic pain symptoms anywhere in the body 
before surgery, sleep impairment at all time points after sur-
gery (1–6 months after surgery) and anxiety levels 2 months 
following surgery differed significantly between the two 
groups. For all of these variables, patients with moderate 
6-months NPSI scores showed higher scores—i.e., more 
impairment—than the group who reported no/low 6 months 
NPSI levels (Table 5).
Next, we examined the QST trajectories for the two 
groups of patients, i.e., those who reported no/low neuro-
pathic pain symptoms, compared to those with moderate 
levels of neuropathic pain symptoms 6  months after sur-
gery in an explorative fashion due to the small size of one 
cluster. Interestingly, the trajectories for many QST sub-
tests were similar for the two groups: no significant dif-
ferences between groups were found for MPT, PPT, VDT, 
mechanical and thermal wind-up at any time point (Table 
6). In contrast, CDT (2, 3, 4 and 6 months after surgery) 
and MPS (2, 3, 4 and 5 months after surgery) differed be-
tween the two groups at several time points, WDT at 4 
and 6 months, CPT at 4 months, HPT at 4 and 6 months 
(Table 6a–c), MDT at 4  months and DMA at 3  months 
after surgery (Table 6b). For all QST measures that dif-
fered between the groups, we found that loss of function 
was associated with no/low levels of neuropathic pain 
symptoms 6 months after surgery. The group who reported 
moderate levels of neuropathic pain symptoms 6  months 
after surgery, in contrast, showed z-scores around zero in 
most instances (95% confidence intervals include zero) and 
were thus less affected in their sensitivity than the no/low 
6-months NPSI group. Furthermore, among the variables 
that did differ between the two groups, only for CDT and 
MPS we detected differences at an early time point after 
F I G U R E  5  Neuropathic pain symptoms 6 months after surgery. 
While 30 participants (81%) reported no or low levels of neuropathic 
pain symptoms 6 months after surgery, seven (19%) reported 
moderate levels of neuropathic pain symptoms. Depicted is a box plot, 
illustrating for each group the minimum to maximum range (whiskers), 
the second and third quartile (lower and upper site of the box), the 
median (black horizontal line within the box), and one outlier (orange 
dot)
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surgery (i.e., from 2 months onward, Figure 6a,b). The ratio 
of DMA presence to DMA absence was higher in the ‘mod-
erate’ compared to ‘no/low’ group 3 months after surgery 
and the other variables differed between the two groups 
only at 4 months after surgery or later, i.e., at a time when 
neuropathic symptoms can already be considered chronic.
T A B L E  5  Comparison of patients with no/low versus moderate 6-months NPSI scores—age, gender, pain, sleep and psychological variables
 
No/low
6-months’ NPSI
Moderate
6-months’ NPSI p-value
Number (n) 30 7  
Age (years; median and 95% CI) 62 (59–70) 54 (43–76) .330
Gender (n)
Women 12 5  
Men 18 2 .133a 
Post-operative data (first 24 hr) (0–10 rating scale)
Pain 2.67 (1.33–3.33) 2.67 (0.67–4.33) .845
Sleep quality 2 (2–3) 2 (1–3) .696
Questionnaire data (scores; median and 95% CI)
NPSI at BL 0 (0–1) 6 (0–19) .026
Sleep Impairment at BL 4 (3–6) 7 (2–14) .071
Sleep Impairment at 1 month 6.5 (4–8) 11 (5–19) .036
Sleep Impairment at 2 months 5.5 (4–8) 9 (3–11) .032
Sleep Impairment at 3 months 5 (3–7) 11 (3–13) .013
Sleep Impairment at 4 months 4 (2–5) 9 (2–17) .010
Sleep Impairment at 5 months 4.8 (3–6) 10 (4–15) .007
Sleep Impairment at 6 months 4 (3–7) 10 (4–15) 0.006
Anxiety at BL 6 (4–8) 9 (0–12) .482
Anxiety at 1 month 4.5 (3–6) 5 (2–11) .506
Anxiety at 2 months 3 (2–5) 7 (3–11) .032
Anxiety at 3 months 3.5 (2–5) 5 (2.71–9.29) .785
Anxiety at 4 months 3 (2–5) 9 (0–10) .100
Anxiety at 5 months 4 (3–5) 8 (1–10) .065
Anxiety at 6 months 3 (2–4) 8 (1–13) .100
Depression at BL 2 (2–5) 3 (0–11) .776
Depression at 1 month 4 (3–5) 7 (1–12) .128
Depression at 2 months 3 (1–5) 4 (1–11.5) .350
Depression at 3 months 3 (1–5) 4 (1–11.5) .582
Depression at 4 months 2.5 (1–6) 6 (1–11) .160
Depression at 5 months 3 (1–6) 8 (1–12) .054
Depression at 6 months 2.5 (1–4) 5 (1–12) .172
Catastrophizing at BL 7.5 (4–15) 9 (0–33) .805
Catastrophizing at 1 month 7.5 (6–16) 18 (7–32) .084
Catastrophizing at 2 months 4.5 (1–13) 7 (4–27) .185
Catastrophizing at 3 months 3 (1–12) 13 (1–29) .160
Catastrophizing at 4 months 2.5 (0–8) 13 (0–30) .213
Catastrophizing at 5 months 3.5 (1–6) 14 (0–32) .149
Catastrophizing at 6 months 3 (0–6) 10 (0–31) .185
Abbreviations: BL, baseline; NPSI, neuropathic pain symptoms inventory.
aBased on Chi square test; all other comparisons are based on Mann–Whitney U test for independent samples. 
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T A B L E  6  Comparison of patients with no/low versus moderate 6-months NPSI scores
 
(a) Thermal QST subtests
No/low 6-months’ NPSI Moderate 6-months’ NPSI p-value
Number (n) 30 7  
QST z values (median and 95% CI)
CDT at 1 month −7.67 (−16.94 to −2.49) −2.94 (−91.76 to 0.75) .312
CDT at 2 months −8.24 (−14.75 to −2.24) 0.13 (−91.76 to 1.88) .036
CDT at 3 months −6.87 (−12.00 to −1.73) 0.02 (−91.76 to 2.15) .026
CDT at 4 months −2.39 (−10.82 to −1.55) −0.06 (−91.76 to 2.30) .015
CDT at 5 months −3.67 (−7.21 to −1.14) −0.71 (−68.12 to 1.77) .199
CDT at 6 months −3.73 (−7.69 to −0.87) 0.19 (−20.55 to 1.99) .036
WDT at 1 month −4.82 (−15.76 to −1.77) −5.70 (−27.24 to −0.32) 1.000
WDT at 2 months −6.58 (−14.88 to −2.18) −4.03 (−27.24 to 1.56) .458
WDT at 3 months −5.22 (−13.96 to −1.68) −2.35 (−27.24 to 1.33) .276
WDT at 4 months −6.46 (−9.99 to −2.49) −1.08 (−27.24 to 1.22) .049
WDT at 5 months −8.15 (−11.79 to −2.16) −0.50 (−26.51 to 0.10) .054
WDT at 6 months −4.69 (−11.13 to −1.96) 0.07 (−26.51 to 0.91) .032
CPT at 1 month −1.12 (−3.19 to −0.12) 0.37 (−13.68 to 1.37) .350
CPT at 2 months −2.17 (−3.91 to −0.27) −0.75 (−13.68 to 1.54) .350
CPT at 3 months −0.53 (−2.71–0.59) 0.91 (−13.68 to 1.92) .531
CPT at 4 months 0.05 (−1.67–0.64) 1.37 (−13.68 to 1.61) .015
CPT at 5 months −0.73 (−1.73–0.59) 0.44 (−10.47 to 1.61) .413
CPT at 6 months −0.23 (−1.87–0.38) 1.11 (−10.47 to 1.61) .160
HPT at 1 month −2.27 (−3.15 to −0.70) 0.56 (−2.94 to 1.43) .138
HPT at 2 months −2.24 (−3.15 to −1.24) −1.71 (−2.94 to 1.26) .243
HPT at 3 months −1.77 (−2.88 to −0.87) −0.38 (−2.94 to 0.69) .138
HPT at 4 months −1.54 (−2.83 to −0.52) 0.52 (−2.94 to 2.82) .010
HPT at 5 months −1.88 (−3.55 to −0.94) −0.12 (−2.94 to 1.00) .276
HPT at 6 months −1.84 (−2.65 to −1.03) −0.17 (−2.94 to 0.62) .036
Therm. WU at 1 month −0.58 (−1.24 to −0.17) −0.96 (−1.27 to 1.82) .747
Therm. WU at 2 months −0.51 (−0.79–0.42) −0.39 (−1.27 to 1.31) .747
Therm. WU at 3 months −0.53 (−0.73–0.50) −0.39 (−1.78 to 0.55) .482
Therm. WU at 4 months −0.31 (−0.83–0.85) −0.82 (−1.26 to 5.71) .925
Therm. WU at 5 months −0.53 (−0.83 to −0.12) 0.05 (−1.04 to 2.00) .231
Therm. WU at 6 months −0.68 (−0.85 to −0.12) 0.16 (−0.96 to 3.30) .118
 
(b) Mechanical, vibration and pressure QST subtests
No/low 6-months’ NPSI Moderate 6-months’ NPSI p-value
Number (n) 30 7  
QST data (median and 95% CI)
MDT at 1 month −15.56 (−71 to −3) −5.99 (−605 to 0) .350
MDT at 2 months −15.05 (−216 to −2) −4.56 (−605 to 0) .556
MDT at 3 months −37.99 (−136 to −3) −1.29 (−605 to 0) .172
MDT at 4 months −18.73 (−72 to −3) −0.19 (−605 to 1) .026
MDT at 5 months −11.12 (−61 to −4) −2.19 (−605 to 1) .092
MDT at 6 months −7.18 (−43 to −2) −4.95 (−605 to 0) .608
(Continues)
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(b) Mechanical, vibration and pressure QST subtests
No/low 6-months’ NPSI Moderate 6-months’ NPSI p-value
MPT at 1 months −7.19 (−13 to −1) −0.51 (−32 to 1) .243
MPT at 2 months −7.75 (−12 to −3) −1.43 (−32 to 0) .172
MPT at 3 months −8.49 (−22 to −3) −0.70 (−32 to 1) .059
MPT at 4 months −6.42 (−13 to −3) −0.51 (−32 to 1) .071
MPT at 5 months −3.45 (−10 to −1) −0.51 (−21 to 1) .185
MPT at 6 months −2.55 (−9 to −1) 0.50 (−15 to 1) .149
MPS at 1 month −1.45 (−2.73 to −0.72) −0.11 (−1.82 to 1.60) .084
MPS at 2 months −1.86 (−2.88 to −1.29) −0.03 (−2.70 to 0.21) .023
MPS at 3 months −2.16 (−2.83 to −1.46) 0.30 (−1.82 to 1.56) <.001
MPS at 4 months −1.84 (−2.65 to −0.86) −0.16 (−2.11 to 0.83) .009
MPS at 5 months −1.94 (−2.91 to −1.45) −0.32 (−1.75 to 1.15) .001
MPS at 6 months −1.73 (−2.75 to −0.92) −0.56 (−1.75 to 1.55) .036
VDT at 1 month −1.01 (−2.18 to −0.50) −0.71 (−12.60 to 0.60) .747
VDT at 2 months −1.59 (−2.61 to −0.95) −0.71 (−2.14 to 1.27) .118
VDT at 3 months −1.64 (−2.18 to −0.65) −0.60 (−2.26 to 3.24) .149
VDT at 4 months −0.84 (−1.96 to −0.29) −0.52 (−2.71 to 0.90) .413
VDT at 5 months −1.20 (−1.96 to −0.33) 0.29 (−3.32 to 0.98) .160
VDT at 6 months −0.51 (−1.38 –0.12) 0.27 (−3.32 to 1.38) .719
PPT at 1 month 1.59 (0.65 to 2.79) 2.35 (−0.38 to 4.50) .227
PPT at 2 months 1.07 (0.54 to 1.58) 0.64 (−0.96 to 2.77) .531
PPT at 3 months 1.23 (0.52 to 2.40) 0.44 (−1.73 to 3.09) .391
PPT at 4 months 1.51 (0.53 to 2.11) 1.19 (−0.54 to 1.91) .293
PPT at 5 months 1.31 (0.15 to 1.61) 0.38 (−0.70 to 2.09) .635
PPT at 6 months 0.89 (0.47 to 1.33) −0.69 (−1.50 to 1.91) .118
Mech. WU at 1 month 0.03 (−0.53 to 1.40) −0.08 (−1.94 to 2.55) .925
Mech. WU at 2 months −0.23 (−0.42 to 0.21) 0.70 (−1.94 to 2.23) .608
Mech. WU at 3 months 0.25 (−0.91 to 1.44) 0.45 (−2.44 to 3.12) .776
Mech. WU at 4 months 0.61 (0.03 to 1.52) −0.35 (−1.94 to 3.28) .391
Mech. WU at 5 months −0.02 (−0.66 to 0.67) 0.29 (−1.23 to 12.87) .435
Mech. WU at 6 months 0.14 (−0.23 to 1.27) 0.02 (−0.96 to 12.87) .865
 
(c) Qualitatively assessed presence of dynamic mechanical allodynia
No/low 6-months’ NPSI moderate 6-months’ NPSI p-value
Number (n) 30 7  
Number of patients with/without DMA 
(n)
With DMA Without DMA With DMA Without DMA  
DMA at 1 month 2 28 3 4 .037
DMA at 2 months 0 30 1 6 .189
DMA at 3 months 0 30 3 4 .005
DMA at 4 months 1 29 2 5 .086
T A B L E  6  (Continued)
(Continues)
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4 |  DISCUSSION
We investigated post-surgical QST trajectories over 6 months 
after thoracotomy, revealing an impairment of the affected 
intercostal nerve with a predominant loss of function. This 
study further revealed preoperative neuropathic pain symp-
toms, possibly in conjunction with sleep impairment within 
the first month after surgery and the presence of DMA 
3 months after surgery, as key factor for an early prediction 
of 6-months NPSI scores.
In line with existing findings of incidence rates be-
tween 10%–33% (Duale et al., 2014; Guastella et al., 2011; 
Hopkins et  al.,  2015; Searle, Simpson, Simpson, Milton, 
& Bennett,  2009; Steegers, Snik, Verhagen, Drift, & 
Wilder-Smith, 2008), seven of 37 (19%) patients in the pres-
ent study reported moderate neuropathic pain 6 months after 
thoracotomy. While the moderate group reported higher 
neuropathic pain anywhere in the body before surgery, more 
anxiety and sleep impairment after surgery, and showed an 
increased likelihood for DMA 3 months after surgery, it was 
the no/low group who showed overall more abnormal QST 
signs—all of which indicated functional loss. Due to rela-
tively small group sizes, these comparisons should be inter-
preted with caution and future research is needed to confirm 
the findings.
A central element of the present study was the monthly QST 
profiles, revealing trajectories of functional loss and gain as a 
consequence of intercostal nerve damage. Across patients, we 
 
(c) Qualitatively assessed presence of dynamic mechanical allodynia
No/low 6-months’ NPSI moderate 6-months’ NPSI p-value
DMA at 5 months 1 29 1 6 .347
months 0 30 1 6 .189
Note: (a and b) All comparisons are based on Mann–Whitney U test for independent samples. Negative z values indicate loss of function, positive ones indicate gain of 
function. (c) All comparisons are based on Chi-Square test.
Abbreviations: CDT, cold detection threshold; CPT, cold pain threshold; HPT, heat pain threshold; MDT, mechanical detection threshold; Mech. WU, mechanical 
wind-up. DMA, dynamic mechanical allodynia; MPS, mechanical pain sensitivity; MPT, mechanical pain threshold; PPT, pressure pain threshold; QST, quantitative 
sensory testing; Therm, WU thermal wind-up; VDT, vibration detection threshold; WDT, warm detection threshold.
T A B L E  6  (Continued)
F I G U R E  6  QST trajectories for (a) CDT and (b) MPS comparing patients who report no/low and moderate neuropathic pain symptoms 
6 months after surgery. Negative symptoms are represented by z-scores below zero. CDT and MPS are the only QST subtests that differed between 
the two groups already at an early time point (2 months following surgery) and across several assessment time points. Loss of function was 
generally associated with low 6-months’ NPSI scores. Depicted are box plots for each group and time point, with circles indicating outliers and 
stars indicating extreme outliers
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observed predominantly functional loss, including increased 
thresholds for mechanical detection, mechanical pain, thermal 
detection thermal pain, and vibration. The only observed gain 
of function was increased sensitivity to pressure pain. The 
presence of functional loss following thoracotomy—at least 
immediately after surgery—is unsurprising, given that a total 
or partial conduction block in the affected nerve around inci-
sion has been reported, using intercostal nerve stimulation and 
measurements of motor evoked potentials, after removal of 
rib retractors (Rogers, Henderson, Mahajan, & Duffy, 2002). 
The QST trajectories in the present sample suggest that most 
negative signs—possibly representing a conduction block—
remain stable for several months. This is comparable to pre-
vious results observed in patients with various peripheral 
nerve lesions, typically reporting loss of function that is still 
present months to even years after the initial onset of nerve 
damage (A. Hartmann et  al.,  2017; Wildgaard et  al.,  2012) 
or a combination of loss and gain of function (Gierthmuhlen 
et  al.,  2012; Pfau et  al.,  2014; Vollert et  al.,  2016). Across 
studies, the most commonly reported types of functional 
loss include decreased sensitivity to warmth, cold, mechan-
ical detection and vibration (Gierthmuhlen et  al.,  2012; A. 
Hartmann et al., 2017; Pfau et al., 2014; Vollert et al., 2016). 
The most commonly reported gain of function is increased 
pressure pain (Gierthmuhlen et al., 2012; Pfau et al., 2014; 
Vollert et al., 2016), as observed here.
In the present study, various QST tests (including sensi-
tivity to thermal and mechanical stimuli) differed between 
patients with no/low versus moderate 6-months NPSI 
scores. Interestingly, though, the findings imply greater im-
pairment of the affected intercostal nerve in the group with 
no/low 6-months NPSI scores. Thus, the degree of self-re-
ported neuropathic pain 6 months after surgery seems to be 
dissociated from the QST profiles. Examining the existing 
literature reveals mixed results for the association between 
neuropathic symptoms and nerve function assessed by QST. 
Across patients with different neuropathies, concordance 
rates between self-reported data and various QST subtests 
were generally weak (Gierthmuhlen, Binder, Forster, & 
Baron, 2018). When correlations were found between the 
measures, they were mainly reported for positive neuro-
pathic pain symptoms, for instance allodynia, hyperalgesia 
(Attal et al., 2008; Freeman, Baron, Bouhassira, Cabrera, 
& Emir, 2014) and increased temporal summation of pain 
(Schreiber, Zinboonyahgoon, Vasudevan, Cornelius, & 
Edwards, 2017). In contrast, QST profiles of the present 
study revealed a clear predominance of negative signs, es-
pecially for the group that reported no/low 6-months NPSI 
scores. Therefore, we conclude that loss of nerve function 
is not a crucial factor for the development of neuropathic 
pain following thoracotomy.
Early factors that did predict chronic neuropathic pain 
symptoms included preoperative neuropathic pain symptoms 
anywhere in the body, and sleep impairment. Preoperative pain 
is consistently found to predict the development of chronic 
neuropathic pain (Duale et al., 2014; Martinez et al., 2015; 
Masselin-Dubois et al., 2013; Mustonen et al., 2018; Noiseux 
et al., 2014; Pereira et al., 2017). Like Dualé et al. (2014), 
we specifically assessed symptoms of neuropathic pain prior 
to surgery and found that a history of neuropathic pain was 
the strongest predictor of chronic neuropathic pain symptoms 
resulting from thoracotomy. This might indicate a genetic 
vulnerability for the development of neuropathies (Zorina-
Lichtenwalter, Meloto, Khoury, & Diatchenko, 2016).
In addition to preoperative neuropathic pain symptoms, 
sleep impairment seemed to play a role in the chronification of 
neuropathic pain symptoms—sleep impairment differentiated 
the groups of low versus moderate 6-months NPSI scores at 
all post-surgical time points. When sleep impairment scores 
from baseline to 3 months after surgery were entered in the re-
gression, there was a trend for sleep impairment 1 month after 
thoracotomy to predict 6-months NPSI scores. In line with re-
cent research, proposing a causal link—rather than a reciprocal 
association –between sleep impartment and the manifestation 
of chronic pain (Gasperi, Herbert, Schur, Buchwald, & Afari, 
2017; Harrison, Wilson, Munafò, & r., & management., 2014; 
Stocks et  al.,  2018), reviewed in (Finan, Goodin, & Smith, 
2013), our findings suggest an influence of sleep impairment 
on the development of chronic neuropathic pain symptoms.
In contrast with physical preoperative predictors, findings 
for psychological predictors of neuropathic pain are less consis-
tent across studies. While some studies report a predictive value 
of affective states for the development of neuropathic symptoms 
(Masselin-Dubois et al., 2013; Mustonen et al., 2018; Noiseux 
et al., 2014), Masselin-Dubois et al. (2013) reported that none 
of the preoperative psychological factors measured (depressive 
symptoms, anxiety, catastrophizing) distinguished the group of 
pain patients with and without neuropathic components after 
surgery. In line with this study, none of the psychological vari-
ables included in the present study differed at baseline between 
the groups of patients with no/low versus moderate 6-months 
NPSI scores. The fact, however, that none of the patients in the 
present study showed severe and only a few patients moderate 
anxiety or depression symptoms before surgery (6/37 and 3/37, 
respectively) (Stern, 2014), may explain why no influence of 
baseline anxiety and depression on the development of chronic 
neuropathic pain symptoms was detected. The earliest time 
point at which a difference in anxiety between the groups was 
observed was 2 months after surgery. However, anxiety levels 
did not add to the prediction of 6-months NPSI scores and may 
therefore be a consequence of experiencing neuropathic symp-
toms rather than a contributing factor to their development.
The emerging picture indicates an important role for 
physical well-being (including pre-existing pain and sleep 
quality) before and immediately after surgery in the devel-
opment of chronic neuropathic pain. While the development 
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of neuropathic post-surgical pain may seem less dependent 
on pre-existing psychological components than described 
for predictors of any type of CPSP (e.g. (Abbott et al., 2011; 
Brandsborg, Nikolajsen, Kehlet, & Jensen,  2008; Fletcher 
et al., 2015; K. E. Hartmann et al., 2004; Jackson et al., 2016; 
Vandyk, Brenner, Tranmer, & Kerkhof,  2011; Weinrib 
et al., 2017)), it may be linked to physical/genetic factors [1; 
10] and appears to be independent of the magnitude of nerve 
damage.
4.1 | Limitations
The sample size of this study is relatively small and the list 
of included risk factors was not exhaustive. Nevertheless, the 
strength of the study is the high density of QST measure-
ments in a patient population with a high risk of neuropathic 
pain development. There are no comparable previous studies 
that assessed thoracotomy patients longitudinally for as many 
time points as we did, running comprehensive QST protocols 
and affective assessments in each session. Given the com-
plexity and length of the testing, it was expected that a con-
siderable number of patients would prematurely terminate 
the study or would have incomplete data sets. We consider 
it a success to obtain complete or nearly complete QST and 
NPSI trajectories of 5 to 7 testing time points for 37 patients.
To keep each testing session to a tolerable length we re-
stricted the number of test variables. Variables that were 
included in addition to the QST data, such as measures of psy-
chological distress (Jackson et al., 2016; Weinrib et al., 2017), 
and sleep impairment (Finan et al., 2013), were chosen because 
of strong evidence for their role in pain chronification. In fact, 
many of the included variables successfully distinguished be-
tween the groups with no/low and moderate 6-months NPSI 
scores. Finally, other factors that have been suggested previ-
ously to possibly have an influence on neuropathic pain de-
velopment after surgery were standardized across patients, 
including surgery technique, the same surgeon for all patients, 
and a standardized anaesthesia/analgesia regime. Overall, this 
study describes trajectories of neuropathic signs and symptoms 
in addition to carefully chosen affective and physical factors in 
patients before and for 6 months following thoracotomy.
5 |  CONCLUSIONS
Independent of the degree of nerve damage, the main pre-
dictors for post-surgical neuropathic pain were related to 
physical well-being before and shortly after surgery. Clinical 
routine should focus on the individual's physiological state 
for example by using easy-to-use self-report questionnaires, 
to identify patients early who are likely to develop chronic 
post-surgical neuropathic pain.
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